Patheon announces changes to its Board of Directors

TORONTO, Feb. 13, 2012 /PRNewswire/ – Patheon Inc. (TSX: PTI), a leading
provider of contract development and manufacturing services to the
global pharmaceutical industry, announced today that Ramsey Frank has
resigned as Chairman of the Board and a Director of Patheon Inc.
effective today. The Board has appointed Paul S. Levy, Managing
Director, JLL Partners, as Patheon’s new Chairman. Mr. Levy joined the
Board in April 2007.

Mr. Levy founded JLL Partners in 1988. Prior to founding JLL Partners,
Mr. Levy was a Managing Director at Drexel Burnham Lambert. Previously,
Mr. Levy was Chief Executive Officer of Yves Saint Laurent Inc., Vice
President of Administration and General Counsel of Quality Care, Inc.,
and an attorney at Stroock & Stroock & Lavan LLP.

Patheon is also pleased to announce the appointment of Nicholas O’Leary,
Associate, JLL Partners, to its Board of Directors, filling the vacant
seat left by the departure of Mr. Frank. Mr. O’Leary joined JLL
Partners in 2009. Prior to that, Mr. O’Leary worked as an analyst with
Merrill Lynch & Co., Mergers and Acquisitions Group. He received a B.A,
Economics from Washington and Lee University, magna cum laude and Phi Beta Kappa.

As well, Mr. Michel Lagarde has been appointed Chair of Patheon’s
Corporate Governance Committee. Mr. Lagarde joined JLL Partners in 2008
and Patheon’s Board of Directors in December 2011. He was previously
the CEO and CFO of the Domestic Appliances and Personal Care division
of Philips Electronics North America. He also held positions as CFO of
Philips Electronics Indonesia and Financial Controller of Philips
Electronics Hong Kong. Mr. Lagarde currently serves on the Boards of
ACE Cash Express and SOS Children’s Villages – USA. He received a B.B.A
from European University Antwerp and an Executive Master in Finance and
Control from the University of Amsterdam.

Mr. Daniel Agroskin, Managing Director at JLL Partners, Inc., and a
current member of the Board, will become a member of Patheon’s
Corporate Governance Committee, filling the position vacated by Mr.
Clark. Mr. Agroskin joined JLL Partners in 2005. Prior to joining JLL,
he worked at JP Morgan Partners and in Merrill Lynch’s Mergers and
Acquisitions Group. Mr. Agroskin is a graduate of Stanford University
and the Wharton School of the University of Pennsylvania. He joined
Patheon’s Board of Directors in December 2009.

About Patheon

Patheon Inc. (TSX: PTI) is a leading global provider of contract
development and manufacturing services to the global pharmaceutical
industry. The company provides the highest quality products and
services to approximately 300 of the world’s leading pharmaceutical and
biotechnology companies. Its services range from preclinical
development through commercial manufacturing of a full array of dosage
forms including parenteral, solid and liquid forms.

The company’s comprehensive range of fully integrated Pharmaceutical
Development Services includes pre-formulation, formulation, analytical
development, clinical manufacturing, scale-up and
commercialization. The company’s integrated development and
manufacturing network of 10 manufacturing facilities, nine development
centers and one clinical trial material packaging facility across North
America and Europe, enables customer products to be launched with
confidence anywhere in the world.

SOURCE Patheon Inc.